NASDAQ:EYES
Second Sight Medical Products, Inc.
- Stock
Last Close
4.36
31/08 04:00
Market Cap
210.05M
Beta: 2.56
Volume Today
35.77K
Avg: -
PE Ratio
−10.28
PFCF: −40.28
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.07M - | 4.03M 95.20% | 6.97M 72.65% | 5.81M 16.55% | 3.06M 47.39% | 2.98M 2.71% | 2.14M 28.08% | 514.50K 75.95% | ||
average payables | 522.85K - | 413.72K 20.87% | 611.55K 47.82% | 933K 52.56% | 954K 2.25% | 1.03M 7.81% | 1.20M 16.58% | 789.50K 34.15% | 502.50K 36.35% | |
average receivables | 418.27K - | 588.15K 40.61% | 1.10M 87.76% | 887.50K 19.63% | 1.05M 18.59% | 1.17M 10.93% | 479.50K 58.93% | 227.50K 52.55% | ||
book value per share | -5.86 - | 30.43 618.88% | 12.52 58.85% | 6.76 45.97% | 3.49 48.36% | 1.12 68.08% | 11.87 964.61% | -0.10 100.83% | 6.25 6,478.31% | |
capex per share | -0.16 - | -0.49 214.82% | -0.47 4.40% | -0.30 36.85% | -0.12 60.50% | -0.06 49.82% | -0.80 1,264.99% | -0.05 94.02% | -0.00 97.34% | |
capex to depreciation | -0.78 - | -2.01 157.64% | -2.27 13.33% | -1.13 50.13% | -0.58 48.88% | -0.37 35.38% | -1.24 231.40% | -2.01 62.04% | -0.20 90.06% | |
capex to operating cash flow | 0.01 - | 0.03 132.24% | 0.04 13.11% | 0.02 47.29% | 0.01 43.38% | 0.01 50.59% | 0.02 226.33% | 0.02 9.94% | 0.00 92.23% | |
capex to revenue | -0.16 - | -0.16 4.91% | -0.09 48.37% | -0.12 44.42% | -0.03 72.94% | -0.02 28.96% | -0.15 517.26% | |||
cash per share | 5.52 - | 30.43 451.60% | 9.86 67.59% | 6.60 33.09% | 3.47 47.35% | 1.62 53.47% | 18.48 1,043.35% | 0.46 97.49% | 6.36 1,273.38% | |
days of inventory on hand | 152.16 - | 586.97 285.75% | 566.08 3.56% | 123.74 78.14% | 192.59 55.64% | 242.69 26.01% | 174.53 28.08% | |||
days payables outstanding | 20.38 - | 52.64 158.26% | 48.96 6.98% | 41.88 14.47% | 53.64 28.10% | 97.45 81.67% | 185.38 90.24% | -354.78 291.38% | -1.46K 310.73% | |
days sales outstanding | 109.31 - | 76.02 30.46% | 61.21 19.47% | 25.10 59.00% | 83.92 234.38% | 26.68 68.21% | 49.15 84.24% | |||
debt to assets | 1.73 - | 0.20 88.64% | 0.28 44.02% | 0.34 19.19% | 0.46 35.47% | 0.71 55.88% | 0.56 21.03% | 1.15 104.85% | 0.04 96.92% | |
debt to equity | -2.37 - | 0.24 110.28% | 0.39 61.36% | 0.51 28.93% | 0.84 65.24% | 2.46 193.56% | 1.28 47.98% | -7.64 695.87% | 0.04 100.48% | |
dividend yield | ||||||||||
earnings yield | -0.03 - | -0.13 312.28% | -0.09 30.36% | -0.43 386.62% | -0.28 35.25% | -0.60 116.56% | -3.08 415.54% | -0.39 87.44% | -0.17 56.88% | |
enterprise value | 772.79M - | 279.53M 63.83% | 228.54M 18.24% | 77.38M 66.14% | 102.83M 32.88% | 54.31M 47.19% | 2.19M 95.97% | 37.50M 1,613.56% | -15.86M 142.31% | |
enterprise value over ebitda | -43.81 - | -10.02 77.12% | -11.63 16.01% | -2.37 79.66% | -3.68 55.45% | -1.57 57.28% | -0.07 95.76% | -2.55 3,727.29% | 1.79 170.36% | |
ev to operating cash flow | -44.34 - | -16.35 63.12% | -11.12 32.00% | -3.09 72.25% | -4.29 39.11% | -1.82 57.57% | -0.08 95.65% | -2.23 2,714.40% | 1.73 177.46% | |
ev to sales | 493.82 - | 82.27 83.34% | 25.53 68.96% | 19.42 23.95% | 12.91 33.51% | 7.88 39.01% | 0.65 91.78% | |||
free cash flow per share | -11.24 - | -15.52 38.05% | -13.17 15.13% | -15.51 17.78% | -10.73 30.81% | -10.84 0.99% | -45.89 323.43% | -2.50 94.55% | -0.84 66.36% | |
free cash flow yield | -0.02 - | -0.06 168.70% | -0.09 47.84% | -0.33 252.13% | -0.23 28.64% | -0.51 117.84% | -2.58 405.33% | -0.45 82.70% | -0.17 61.41% | |
graham net net | -7.44 - | 25.98 449.32% | 8.16 68.59% | 4.32 47.02% | 1.75 59.54% | -0.41 123.23% | 4.66 1,247.84% | -0.29 106.11% | 6.13 2,251.20% | |
graham number | 43.90 - | 145.54 231.52% | 59.03 59.44% | 55.35 6.23% | 31.52 43.06% | 17.84 43.39% | 121.00 578.16% | 2.19 98.19% | 10.71 389.64% | |
income quality | 0.76 - | 0.49 36.00% | 1.03 111.41% | 0.76 26.39% | 0.84 11.14% | 0.85 1.15% | 0.82 3.17% | 1.13 37.45% | 1.03 8.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -3.59 - | -3.02 15.91% | -691.28 22,800.16% | -1.07K 54.97% | -307.62 71.28% | -409.07 32.98% | -93.80 77.07% | -931 892.58% | -744.42 20.04% | |
interest debt per share | 15.41 - | 6.18 59.87% | 0.02 99.71% | 0.02 4.97% | 0.04 119.13% | 0.03 24.56% | 4.84 15,454.30% | 0.32 93.32% | 0.02 92.96% | |
inventory turnover | 2.40 - | 0.62 74.08% | 0.64 3.69% | 2.95 357.47% | 1.90 35.75% | 1.50 20.64% | 2.09 39.05% | |||
invested capital | -2.08 - | 0.36 - | -3.27 1,015.33% | 0.00 100.11% | ||||||
market cap | 753.64M - | 280.15M 62.83% | 228.77M 18.34% | 77.92M 65.94% | 103.43M 32.74% | 58.78M 43.17% | 10.91M 81.43% | 38.48M 252.55% | 53.49M 39.03% | |
net current asset value | -10.11M - | 33.52M 431.71% | 18.78M 43.98% | 9.62M 48.78% | 6.55M 31.91% | 2.02M 69.13% | 3.79M 87.24% | -863K 122.79% | 67.99M 7,978.68% | |
net debt to ebitda | -1.09 - | 0.02 102.05% | 0.01 45.25% | 0.02 35.48% | 0.02 31.09% | 0.13 498.77% | 0.27 105.49% | 0.07 74.99% | 7.85 11,706.02% | |
net income per share | -14.61 - | -30.94 111.82% | -12.37 60.02% | -20.13 62.76% | -12.64 37.22% | -12.69 0.40% | -54.81 331.99% | -2.17 96.04% | -0.82 62.41% | |
operating cash flow per share | -11.08 - | -15.02 35.56% | -12.70 15.48% | -15.21 19.80% | -10.61 30.23% | -10.78 1.55% | -45.08 318.29% | -2.45 94.56% | -0.84 65.76% | |
payables turnover | 17.91 - | 6.93 61.28% | 7.45 7.50% | 8.72 16.92% | 6.80 21.93% | 3.75 44.95% | 1.97 47.43% | -1.03 152.25% | -0.25 75.65% | |
receivables turnover | 3.34 - | 4.80 43.79% | 5.96 24.18% | 14.54 143.91% | 4.35 70.09% | 13.68 214.57% | 7.43 45.72% | |||
research and ddevelopement to revenue | 2.08 - | 1.48 28.53% | 0.34 77.14% | 1.34 295.55% | 0.99 26.14% | 1.45 46.39% | 3.89 168.09% | |||
return on tangible assets | -1.81 - | -0.82 54.90% | -0.71 13.29% | -1.97 178.49% | -1.97 0.34% | -3.29 67.02% | -2.02 38.40% | -3.34 64.86% | -0.13 96.23% | |
revenue per share | 1.00 - | 2.99 200.09% | 5.53 85.17% | 2.42 56.28% | 3.53 45.98% | 2.49 29.36% | 5.51 121.14% | |||
roe | 2.49 - | -1.02 140.82% | -0.99 2.85% | -2.98 201.27% | -3.62 21.56% | -11.38 214.53% | -4.62 59.42% | 22.14 579.55% | -0.13 100.59% | |
roic | -1.47 - | -0.51 65.07% | -0.74 44.17% | -2.28 207.51% | -2.28 0.16% | -80.87 3,444.03% | 4.75 105.87% | 6.26 31.76% | 0.13 97.93% | |
sales general and administrative to revenue | 2.66 - | 1.93 27.45% | 0.92 52.45% | 2.53 175.31% | 1.37 45.73% | 1.55 12.95% | 2.73 76.10% | |||
shareholders equity per share | -5.86 - | 30.43 618.88% | 12.52 58.85% | 6.76 45.97% | 3.49 48.36% | 1.12 68.08% | 11.87 964.61% | -0.10 100.83% | 6.25 6,478.31% | |
stock based compensation to revenue | 0.49 - | 0.43 11.78% | 0.30 30.82% | 0.84 181.43% | 0.48 43.77% | 0.52 9.54% | 0.87 66.33% | |||
tangible asset value | -9.22M - | 34.62M 475.43% | 20.26M 41.47% | 11.15M 44.98% | 7.88M 29.30% | 3.08M 60.87% | 7.28M 135.89% | -672K 109.24% | 68.36M 10,273.36% | |
tangible book value per share | -5.86 - | 30.43 618.88% | 12.52 58.85% | 6.76 45.97% | 3.49 48.36% | 1.12 68.08% | 11.87 964.61% | -0.10 100.83% | 6.25 6,478.31% | |
working capital | 9.10M - | 33.52M 268.23% | 18.78M 43.98% | 9.62M 48.78% | 6.55M 31.91% | 2.02M 69.13% | 6.15M 204.20% | -863K 114.03% | 68.05M 7,984.70% |
All numbers in USD (except ratios and percentages)